ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,100.02
0.03%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. iTeos Therapeutics Inc (ITOS)

  7. iTeos Therapeutics Inc (ITOS) Noticias

ITOS

iTeos Therapeutics (ITOS)

iTeos Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ITOS
FechaHoraFuenteTítuloSímboloCompañía
13/05/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITOSiTeos Therapeutics Inc
10/05/202415:35Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ITOSiTeos Therapeutics Inc
10/05/202407:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITOSiTeos Therapeutics Inc
10/05/202407:26GlobeNewswire Inc.iTeos Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
10/05/202407:24GlobeNewswire Inc.iTeos Therapeutics Announces $120 Million Registered Direct OfferingNASDAQ:ITOSiTeos Therapeutics Inc
07/04/202415:30GlobeNewswire Inc.iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024NASDAQ:ITOSiTeos Therapeutics Inc
08/03/202419:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
07/03/202419:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
06/03/202406:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ITOSiTeos Therapeutics Inc
06/03/202406:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ITOSiTeos Therapeutics Inc
06/03/202406:01GlobeNewswire Inc.iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of DirectorsNASDAQ:ITOSiTeos Therapeutics Inc
06/03/202406:00GlobeNewswire Inc.iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
05/03/202415:30GlobeNewswire Inc.iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024NASDAQ:ITOSiTeos Therapeutics Inc
01/03/202406:00GlobeNewswire Inc.iTeos to Participate in Upcoming Investor ConferencesNASDAQ:ITOSiTeos Therapeutics Inc
08/01/202406:00GlobeNewswire Inc.iTeos Announces 2024 Strategic Priorities and Anticipated MilestonesNASDAQ:ITOSiTeos Therapeutics Inc
03/01/202406:00GlobeNewswire Inc.iTeos to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ITOSiTeos Therapeutics Inc
21/11/202306:00GlobeNewswire Inc.iTeos to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ITOSiTeos Therapeutics Inc
07/11/202306:00GlobeNewswire Inc.iTeos Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
11/10/202316:55PR Newswire (US)NCR Atleos Set to Join S&P SmallCap 600NASDAQ:ITOSiTeos Therapeutics Inc
08/08/202306:00GlobeNewswire Inc.iTeos Reports Second Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
26/06/202306:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ITOSiTeos Therapeutics Inc
15/06/202318:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ITOSiTeos Therapeutics Inc
22/05/202305:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ITOSiTeos Therapeutics Inc
10/05/202306:53Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ITOSiTeos Therapeutics Inc
10/05/202306:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ITOSiTeos Therapeutics Inc
10/05/202306:01GlobeNewswire Inc.iTeos Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
27/04/202306:15Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ITOSiTeos Therapeutics Inc
27/04/202306:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ITOSiTeos Therapeutics Inc
27/04/202306:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ITOSiTeos Therapeutics Inc
15/03/202306:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ITOSiTeos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ITOS

Su Consulta Reciente

UNSW
SHIBETH
SHIBA INU
TG
PER
Pernod Ricard
COIN
NMNUSD
NYSE
SDLP
Seadrill Partners
TSXV
TME
Temex Resources Corp.
LATK
SANETH
Santiment Network Token
CSE
SPEY
Spey Resources
LSE
96UL
Euro.bk. 41
EU
F896S
F896S
USOTC
POFCF
Petrofac Ltd London (PK)
LSE
ZWEE
Bmo Enhanced Eu
LSE
SR14
Hsbc Bk. 23
NASDAQ
AAYOYXX
Torontodominion Bank Aut...
ASX
NCMIOB
NASDAQ
ARIFX
Aristotle International ...
NASDAQ
CCIX
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados